Treatment of acute bacterial infections of the upper respiratory tract

References

• Ball A. P., Gray J. A., McC Murdoch J. Antibacterial drugs today. Curr. Therapeutics 1975; 16: 971. Ball A. P., Gray J. A., McC Murdoch J. Antibacterial drugs today. Curr. Therapeutics 1975; 16: 97
   Google Scholar
• Christie A. B. Advances in the treatment of infectious diseases. Practitioner 1970; 205: 5162. Christie A. B. Advances in the treatment of infectious diseases. Practitioner 1970; 205: 516
   Google Scholar
• Chun A. H., Wiegand R. G. Proc. Acad. Pharmacol. Sci. Symposium. Am. Pharmacol. Assoc. 19713. Chun A. H., Wiegand R. g. Proc. Acad. Pharmacol. Sci. Symposium. Am. Pharmacol. Assoc. 1971
   Google Scholar
• Committee on Drugs. Requiem for tetracyclines. Pediatrics 1975; 55: 1424. Committee on Drugs. Requiem for tetracyclines. Pediatrics 1975; 55: 142
   PubMedGoogle Scholar
• Datta N., Faiers M. C., Reeves D. S., Brumfitt W., Orskov F., Ørskov I. R-factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet 1971; 1: 3125. Datta N., Faiers M. C., Reeves D. S., Brumfitt W., Orskov F., Ørskov I. R-factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet 1971; 1: 312
   PubMed Web of Science ®Google Scholar
• Kavanagh F., Dennim L. J. Analytical Microbiology. Academic Press, Indianapolis 19636. Kavanagh F., Dennim L. J. Analytical Microbiology. Academic Press, Indianapolis 1963
   Google Scholar
• Knothe H., Wiedemann B. Development of resistant enterobacteria in the bowel after treatment with tetracycline and erythromycin. Proc. 9th Int. Cong. Chemotherapy, London. Abst. No. M. 353. Plenum, New York 19757. Knothe H., Wiedemann B. Development of resistant enterobacteria in the bowel after treatment with tetracycline and erythromycin. Proc. 9th Int. Cong. Chemotherapy, London. Abst. No. M. 353. Plenum, New York 1975
   Google Scholar
• Lake B. AmpiciUin in acute infections of general practice: a controlled trial. Med. J. Aust. 1971; 1: 6368. Lake B. AmpiciUin in acute infections of general practice: a controlled trial. Med. J. Aust. 1971; 1: 636
   PubMed Web of Science ®Google Scholar
• Leading article. Transferable antibiotic resistance on Teesside. Br. Med. J. 1968; 1: 2639. Leading article. Transferable antibiotic resistance on Teesside. Br. Med. J. 1968; 1: 263
   PubMed Web of Science ®Google Scholar
• Loosli C. G. Synergism between respiratory viruses and bacteria. Yale J. Biol. Med. 1968; 40: 52210. Loosli C. g. Synergism between respiratory viruses and bacteria. Yale J. Biol. Med. 1968; 40: 522
   PubMed Web of Science ®Google Scholar
• Lowbury E. J. Rationale for controlling the emergence of drug resistance. Proc. 9th Int. Cong. Chemotherapy, 3, 187, J. Williams, A. M. Geddes. Plenum, New York 197511. Lowbury E. J. Rationale for controlling the emergence of drug resistance. Proc. 9th Int. Cong. Chemotherapy, 3, 187, J. Williams, A. M. Geddes. Plenum, New York 1975
   Google Scholar
• Lowbury E. J., Cason J. S. Aureomycin and erythromycin therapy for Streptococcus pyogenes in burns. Br. Med. J. 1954; 2: 91412. Lowbury E. J., Cason J. S. Aureomycin and erythromycin therapy for Streptococcus pyogenes in burns. Br. Med. J. 1954; 2: 914
   PubMed Web of Science ®Google Scholar
• Manners B. T. B., Grob P. R., Beyron S. P. J., Gibbs F. J. An investigation of antibiotic resistance of Staphylococcus aureus in general practice. Practitioner 1976; 216: 43913. Manners B. T. B., Grob P. R., Beyron S. P. J., Gibbs F. J. An investigation of antibiotic resistance of Staphylococcus aureus in general practice. Practitioner 1976; 216: 439
   PubMedGoogle Scholar
• Mitchell R. g., Baber K. G. Infections by tetracycline-resistant haemolytic streptococci. Lancet 1965; 1: 2514. Mitchell R. g., Baber K. g. Infections by tetracycline-resistant haemolytic streptococci. Lancet 1965; 1: 25
   PubMed Web of Science ®Google Scholar
• Robertson M. H. Tetracycline resistant beta-haemolytic streptococci in South West Essex; decline and fall. Br. Med. J. 1973; 3: 8415. Robertson M. H. Tetracycline resistant beta-haemolytic streptococci in South West Essex; decline and fall. Br. Med. J. 1973; 3: 84
   PubMedGoogle Scholar
• Robson H. G. Susceptibility of Streptococcus pneumoniae (Pneumococcus) to penicillin, erythromycin and tetracycline. Proc. 9th Int. Cong. Chemotherapy, London. Abst. No. M. 489. Plenum, New York 197516. Robson H. g. Susceptibility of Streptococcus pneumoniae (Pneumococcus) to penicillin, erythromycin and tetracycline. Proc. 9th Int. Cong. Chemotherapy, London. Abst. No. M. 489. Plenum, New York 1975
   Google Scholar
• Ross P. W. Beta-haemolytic streptococci in saliva. J. Hyg. (Camb.) 1971; 69: 34717. Ross P. W. Beta-haemolytic streptococci in saliva. J. Hyg. (Camb.) 1971; 69: 347
   PubMedGoogle Scholar
• Ross S., Rodrigues W., Controni G., Khan W. Staphylococcal susceptibility to penicillin g. The changing patterns among community strains. J.A.M.A. 1974; 229: 107518. Ross S., Rodrigues W., Controni g., Khan W. Staphylococcal susceptibility to penicillin g. The changing patterns among community strains. J.A.M.A. 1974; 229: 1075
   PubMed Web of Science ®Google Scholar
• Rubbo S. D. Common sense in chemotherapy. Med. J. Aust. 1969; 1: 43119. Rubbo S. D. Common sense in chemotherapy. Med. J. Aust. 1969; 1: 431
   PubMed Web of Science ®Google Scholar
• Scott A. J., Nicholson G. I. The recognition of pseudomembranous colitis as a clinical entity. Aust. N.Z. J. Med. 1974; 4: 50220. Scott A. J., Nicholson g. I. The recognition of pseudomembranous colitis as a clinical entity. Aust. N.Z. J. Med. 1974; 4: 502
   PubMedGoogle Scholar
• Seifert M. H. Use and abuse of antibiotic and chemotherapeutic remedies. J. Med. J. 1973; 144: 6421. Seifert M. H. Use and abuse of antibiotic and chemotherapeutic remedies. J. Med. J. 1973; 144: 64
   Google Scholar
• Shapiro S., Sloane D., Siskind V., Lewis G. P. Drug rash with ampiciUin and other penicillins. Lancet 1969; 2: 96922. Shapiro S., Sloane D., Siskind V., Lewis g. P. Drug rash with ampiciUin and other penicillins. Lancet 1969; 2: 969
   PubMed Web of Science ®Google Scholar
• Shaw E. J. Recent changes in bacterial resistance to antibiotics. Practitioner 1974; 213: 48723. Shaw E. J. Recent changes in bacterial resistance to antibiotics. Practitioner 1974; 213: 487
   PubMedGoogle Scholar
• Tedesco F. J., Stanley R. J., Alpers D. Diagnostic features of clindamycin-associated seromembranous colitis. N. Engl. J. Med. 1971; 290: 8424. Tedesco F. J., Stanley R. J., Alpers D. Diagnostic features of clindamycin-associated seromembranous colitis. N. Engl. J. Med. 1971; 290: 84
   Google Scholar